Midatech Pharma Competitors and Similar CompaniesClear all
Quark Pharmaceuticals's competitors and similar companies include KemPharm and Juno Therapeutics.
 Quark Pharmaceuticals Quark Pharmaceuticalsis a clinical-stage pharmaceutical company engaged in the discovery and development of novel RNAi-based therapeutics. |  KemPharm KemPharm is a biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases. |  Juno Therapeutics Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer. | |
Founding Date | Founding Date 1994 | Founding Date 2006 | Founding Date 2013 |
Type | Type Private | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Newark, US HQ | Locations Kissimmee, US HQ Blacksburg, US Coralville, US Coralville, US | Locations Seattle, US HQ Göttingen, DE Göttingen, DE München, DE München, DE Bothell, US Brisbane, US |
Employees | Employees 781% decrease | Employees 333% increase | Employees 1091% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $106.5m (FY, 2025) | Revenue (est.) $111.9m (FY, 2017) |
Net income | Net income N/A | Net income $83.2m (FY, 2025) | Net income ($437.1m) (FY, 2017) |
Funding | |||
Total funding raised | Total funding raised $ 37m | Total funding raised N/A | Total funding raised $ 310m |
For sources of this data, please see the company profile
View Company Profiles
KemPharm
HQ
Kissimmee, US
Employees
33↑ 3% increase
KemPharm is a biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases.
View companyJuno Therapeutics
HQ
Seattle, US
Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer.
View company